Target type: biologicalprocess
The chemical reactions and pathways resulting in the breakdown of aspartate, the anion derived from aspartic acid, 2-aminobutanedioic acid. [GOC:go_curators, ISBN:0198506732]
Aspartate catabolic process is a fundamental metabolic pathway that breaks down the amino acid aspartate, generating energy and essential metabolic intermediates. The process involves a series of enzymatic reactions, primarily occurring in the mitochondria of eukaryotic cells.
The first step involves the deamination of aspartate by the enzyme aspartate aminotransferase, converting aspartate into oxaloacetate. This reaction also generates glutamate, which can be further utilized in other metabolic pathways.
Oxaloacetate is a key intermediate in the citric acid cycle, also known as the Krebs cycle. Here, it enters the cycle and undergoes a series of reactions, leading to the production of ATP (adenosine triphosphate), the primary energy currency of cells. Additionally, the cycle produces reducing equivalents in the form of NADH (nicotinamide adenine dinucleotide) and FADH2 (flavin adenine dinucleotide), which are used in oxidative phosphorylation to generate more ATP.
The aspartate catabolic process is tightly regulated and integrated with other metabolic pathways. It plays a critical role in amino acid metabolism, providing carbon skeletons for gluconeogenesis (the synthesis of glucose from non-carbohydrate sources) and supplying intermediates for the citric acid cycle. Furthermore, it contributes to nitrogen excretion through the urea cycle.
In summary, the aspartate catabolic process is a central metabolic pathway that links amino acid catabolism to energy production and other essential metabolic processes.'
"
Protein | Definition | Taxonomy |
---|---|---|
D-aspartate oxidase | A D-aspartate oxidase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q99489] | Homo sapiens (human) |
Aspartate aminotransferase, cytoplasmic | An aspartate aminotransferase, cytoplasmic that is encoded in the genome of human. [PRO:DNx, UniProtKB:P17174] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
benzoic acid | aromatic carboxylic acid : Any carboxylic acid in which the carboxy group is directly bonded to an aromatic ring. benzoic acid : A compound comprising a benzene ring core carrying a carboxylic acid substituent. Benzoic Acid: A fungistatic compound that is widely used as a food preservative. It is conjugated to GLYCINE in the liver and excreted as hippuric acid. | benzoic acids | algal metabolite; antimicrobial food preservative; drug allergen; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 3.1.1.3 (triacylglycerol lipase) inhibitor; human xenobiotic metabolite; plant metabolite |
malonic acid | dicarboxylic acid : Any carboxylic acid containing two carboxy groups. malonic acid : An alpha,omega-dicarboxylic acid in which the two carboxy groups are separated by a single methylene group. | alpha,omega-dicarboxylic acid | human metabolite |
niacin | Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties. nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group. vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms). | pyridine alkaloid; pyridinemonocarboxylic acid; vitamin B3 | antidote; antilipemic drug; EC 3.5.1.19 (nicotinamidase) inhibitor; Escherichia coli metabolite; human urinary metabolite; metabolite; mouse metabolite; plant metabolite; vasodilator agent |
hydralazine | hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent. Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent. | azaarene; hydrazines; ortho-fused heteroarene; phthalazines | antihypertensive agent; vasodilator agent |
thiophene-3-carboxylic acid | thiophene-3-carboxylic acid: structure in first source | ||
3-aminobenzoic acid | 3-aminobenzoic acid : An aminobenzoic acid carrying an amino group at position 3. 3-aminobenzoic acid: RN given refers to parent cpd | aminobenzoic acid | |
hydralazine hydrochloride | hydralazine hydrochloride : The hydrochloride salt of hydralazine; a direct-acting vasodilator that is used as an antihypertensive agent. | hydrochloride | antihypertensive agent; vasodilator agent |
5-chlorosalicylic acid | 5-chlorosalicylic acid : A monohydroxybenzoic acid that is 2-hydroxybenzoic acid (salicylic acid) in which the hydrogen at position 5 is replaced by chlorine. 5-chlorosalicylic acid: major metabolite of meseclazone; RN given refers to parent cpd | chlorobenzoic acid; monochlorobenzenes; monohydroxybenzoic acid | |
3-aminopyridine | |||
dihydralazine | Dihydralazine: 1,4-Dihydrazinophthalazine. An antihypertensive agent with actions and uses similar to those of HYDRALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p354) | phthalazines | |
3,5-pyridinedicarboxylic acid | 3,5-pyridinedicarboxylic acid: structure in first source | pyridinedicarboxylic acid | |
3-hydroxypicolinic acid | monocarboxylic acid; monohydroxypyridine | MALDI matrix material | |
3-hydroxy-1-benzopyran-2-one | 3-hydroxycoumarin: Photoprotective from sea urchin gametes and embryonic cells; structure in first source hydroxycoumarin : Any coumarin carrying at least one hydroxy substituent. | hydroxycoumarin | |
6-aminonicotinic acid | 6-aminonicotinic acid : An aminonicotinic acid in which the amino group is situated at position 6 of the pyridine ring. 6-aminonicotinic acid: RN given refers to parent cpd | aminonicotinic acid; aminopyridine; aromatic amine | metabolite |
5-hydroxynicotinic acid | aromatic carboxylic acid; pyridines | ||
adapalene | adapalene : A naphthoic acid that is CD437 in which the phenolic hydroxy group has been converted to its methyl ether. Adapalene: A naphthalene derivative that has specificity for RETINOIC ACID RECEPTORS. It is used as a DERMATOLOGIC AGENT for the treatment of ACNE. | adamantanes; monocarboxylic acid; naphthoic acid | dermatologic drug; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor; non-steroidal anti-inflammatory drug |
ziprasidone | ziprasidone : A piperazine compound having 1,2-benzothiazol-3-yl- and 2-(6-chloro-1,3-dihydro-2-oxindol-5-yl)ethyl substituents attached to the nitrogen atoms. ziprasidone: a benzisothiazoylpiperazine derivative; has combined dopamine and serotonin receptor antagonist activity; structurally related to tiospirone | 1,2-benzisothiazole; indolones; organochlorine compound; piperazines | antipsychotic agent; dopaminergic antagonist; histamine antagonist; muscarinic antagonist; psychotropic drug; serotonergic antagonist |
5-fluorosalicylic acid | 5-fluorosalicylic acid: structure given in first source; product from action of alkaline phosphatase on 5-fluorosalicyl phosphate; forms highly fluorescent terbium ternary complex | ||
indole-2-carboxylic acid | indolyl carboxylic acid | ||
2-aminonicotinic acid | 2-aminonicotinic acid : An aminonicotinic acid in which the amino group is situated at position 2 of the pyridine ring. 2-aminonicotinic acid: structure in first source aminonicotinic acid : An aromatic amino acid that is nicotinic acid in which one of the hydrogens attached to the pyridine ring is replaced by an amino group. A 'closed class'. | aminonicotinic acid; aminopyridine | metabolite |
3-aminopicolinic acid | |||
5-bromonicotinic acid | 5-bromonicotinic acid: structure given in first source | ||
5-fluoro-3-pyridinecarboxylic acid | |||
aminopyridazine | aminopyridazine: structure in first source | ||
5-aminonicotinic acid | 5-aminonicotinic acid : An aminonicotinic acid in which the amino group is situated at position 5 of the pyridine ring. 5-aminonicotinic acid: an inhibitor of D-aspartate oxidase; structure in first source | aminonicotinic acid; aminopyridine; aromatic amine | metabolite |
crotonic acid | butenoic acid : Any C4, straight-chain fatty acid containing one double bond. crotonic acid : A but-2-enoic acid with a trans- double bond at C-2. It has been isolated from Daucus carota. crotonic acid: a stereospecific unsaturated carboxylic acid found in CROTON OIL | 2-butenoic acid | plant metabolite |
3-coumaric acid | 3-coumaric acid : A monohydroxycinnamic acid in which the hydroxy substituent is located at C-3 of the phenyl ring. 3-coumaric acid: RN given refers to cpd without isomeric designation in Chemline trans-3-coumaric acid : A 3-coumaric acid that is phenol substituted with trans-2-propenoic acid at position C-3. | 3-coumaric acid | |
3-hydroxyquinolin-2(1h)-one | 3-hydroxyquinolin-2(1H)-one: structure in first source dihydroxyquinoline : Any hydroxyquinoline in which the number of hydroxy substituents is specified as two. | hydroxyquinoline; quinolone | |
6-Chlorobenzo[d]isoxazol-3-ol | benzisoxazole | ||
sun |